A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Recruiting now
Conditions studied: Pancreatic Neoplasms
In brief
The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for Pancreatic Cancer.
Key facts
- Study ID
- NCT03250078
- Run by
- Nuvance Health
- People needed
- 200
- Starts
- 2016-11-01
- Expected to finish
- 2030-11-01
- Last updated by the study team
- 2026-04-13
Who can join
Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Nuvance Health — Norwalk, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.